[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368330-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368330-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","anti-colorectal-cancer-activity-of-panax-and-its-active-components-ginsenosides-a-review","Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review","","Colorectal cancer (CRC) poses a significant health burden worldwide and necessitates novel treatment approaches with fewer side effects than conventional chemotherapy. Many natural compounds have been tested as possible cancer treatments. Plants in the genus Panax have been widely studied for their therapeutic potential in inflammatory disorders and cancers. Panax extracts activate upstream signals linked to autophagy and reactive oxygen species to induce intrinsic apoptosis in CRC cells, with ginsenosides showing anti-proliferative activity, immune checkpoint targeting, and improved drug delivery potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/anti-colorectal-cancer-activity-of-panax-and-its-active-components-ginsenosides-a-review/368330/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/anti-colorectal-cancer-activity-of-panax-and-its-active-components-ginsenosides-a-review/368330.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is colorectal cancer challenging to treat with conventional chemotherapy?","Question",{"text":63,"@type":64},"Conventional chemotherapies can have significant side effects and limited tumor selectivity, and drug resistance associated with colorectal cancer mechanisms (e.g., MSI) reduces effectiveness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do Panax extracts affect colorectal cancer cells?",{"text":68,"@type":64},"Panax extracts activate upstream signals related to autophagy and reactive oxygen species, leading to intrinsic apoptosis in CRC cells.",{"name":70,"@type":61,"acceptedAnswer":71},"Which ginsenosides are highlighted for anti-CRC activity, and what outcomes are reported?",{"text":72,"@type":64},"Protopanaxadiol (PPD)-type ginsenosides—especially Rh2, Rg3, Rb1, and Rb2—reduce CRC cell proliferation and tumor size in a xenograft mouse model, and they also target PD-1 to affect immune checkpoint signaling.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368330,1791276226,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Review  \nAnti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review  \nHan Su Kang †, Hyun Kyung Lim †, Won Young Jang  and Jae Youl Cho *  \nAcademic Editor: Carmine Stolfi  \nReceived: 16 February 2025  \nRevised: 12 March 2025  \nAccepted: 12 March 2025  \nPublished: 13 March 2025  \nCitation: Kang, H.S.; Lim, H.K.; Jang, W.Y.; Cho, J.Y. Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: AReview.  \nInt. J. Mol. Sci. 2025, 26, 2593. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26062593](doi.org/10.3390/ijms26062593)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea;  \n[ssu2010@naver.com](ssu2010@naver.com) (H.S.K.); [lhk1091605@naver.com](lhk1091605@naver.com) (H.K.L.); [wybest0327@naver.com](wybest0327@naver.com) (W.Y.J.)  \n* [Correspondence: jaecho@skku.edu](Correspondence: jaecho@skku.edu); Tel.: +82-31-290-7868 † These authors contributed equally to this work.  \nAbstract: Colorectal cancer (CRC) poses a significant health burden worldwide and necessitates novel treatment approaches with fewer side effects than conventional chemotherapy. Many natural compounds have been tested as possible cancer treatments. Plants in the genus Panax have been widely studied due to their therapeutic potential for various diseases such as inflammatory disorders and cancers. Extracts from plants of genus Panax activate upstream signals, including those related to autophagy and the generation of reactive oxygen species, to induce intrinsic apoptosis in CRC cells. The root extract of Panax notoginseng (P. notoginseng) regulated the gut microbiota to enhance the T-cell-induced immune response against CRC. Protopanaxadiol (PPD)-type ginsenosides, especially Rh2, Rg3, Rb1, and Rb2, significantly reduced proliferation of CRC cells and tumor size in a xenograft mouse model, as well as targeting programmed death (PD)-1 to block the immune checkpoint of CRC cells. Moreover, modified nanocarriers with ginsenosides upregulated drug efficacy, showing that ginsenosides can also be utilized as drug carriers. An increasing body of studies has demonstrated the potential of the genus Panax in curing CRC. Ginsenosides are promising active compounds in the genus Panax, which can also support the activity of conventional cancer therapies.  \nKeywords: colorectal cancer; genus Panax; ginsenosides; anti-cancer; drug delivery  \n1. Introduction  \nColorectal cancer (CRC) has the third-highest incidence and mortality among cancers worldwide [1] . CRC can occur through three different mechanisms, namely the CpG island methylator phenotype (CIMP), chromosomal instability (CIN), and microsatellite instability (MSI) [2] . CpG island hypermethylation induces the transcriptional deactivation of tumor suppressor genes [3] . The CIN pathway results in the mutation of KRAS, TP53 and APC, which are oncogene and tumor suppressor genes, respectively [4,5] . MSI is driven by an impaired DNA mismatch repair system. In total, 15% of CRC patients show MSI and, in these cases, conventional chemotherapies do not work well [6] . Drug resistance related to MSI makes it hard to cure CRC [7] . The high mortality rate of CRC is also attributed to its ability to metastasize well, especially in the peritoneum and liver [8] . Synchronous metastasis is most common in the liver in approximately 20% of patients, and metachronous metastasis occurs within 5 years in up to 60% of patients [9] . Patients with poor prognosis often exert metastasis in the peritoneum.  \nIn the early stages of CRC, tumors can be removed via surgical procedures [1","cbCaisGZsweYbu7u","https://ap.wps.com/l/cbCaisGZsweYbu7u","pdf",1719334,"English","# Introduction\n## Colorectal cancer mechanisms\n## Current therapies and limitations\n## Panax genus and pharmacological background","[{\"question\":\"Why is colorectal cancer challenging to treat with conventional chemotherapy?\",\"answer\":\"Conventional chemotherapies can have significant side effects and limited tumor selectivity, and drug resistance associated with colorectal cancer mechanisms (e.g., MSI) reduces effectiveness.\"},{\"question\":\"How do Panax extracts affect colorectal cancer cells?\",\"answer\":\"Panax extracts activate upstream signals related to autophagy and reactive oxygen species, leading to intrinsic apoptosis in CRC cells.\"},{\"question\":\"Which ginsenosides are highlighted for anti-CRC activity, and what outcomes are reported?\",\"answer\":\"Protopanaxadiol (PPD)-type ginsenosides—especially Rh2, Rg3, Rb1, and Rb2—reduce CRC cell proliferation and tumor size in a xenograft mouse model, and they also target PD-1 to affect immune checkpoint signaling.\"}]","Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review | PDF",1790176349,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea9817dfaf61617179a6e7612209e911.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f58f02a7157939a0520f88824a3662f1.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56f6ca09e5fd38a603e64cbb99c01c17.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0ebd385395f18e628476adafc58036f.webp",980,1385]